Reverse auction procurement requirement modification for SEGIP pharmacy benefit contracts

Minnesota Senate Bill SF3063 aims to reform how pharmacy benefits are managed for state employees. It proposes banning 'spread pricing,' where pharmacy benefit managers (PBMs) charge health plans more for medications than they pay pharmacies. The bill also seeks to increase licensing fees for PBMs and impose fiduciary duties, requiring them to act in the best interests of health carriers. These changes are intended to enhance transparency and fairness in prescription drug pricing for state employees.

Supporters of SF3063 argue that the bill will lead to cost savings for the State Employee Group Insurance Program (SEGIP) by eliminating spread pricing and ensuring PBMs operate transparently. They believe these reforms will result in fairer drug pricing and better financial management of state resources.

Critics of the bill express concerns that imposing fiduciary duties and banning spread pricing could reduce the flexibility of PBMs, potentially leading to higher administrative costs. They worry that these changes might inadvertently increase overall healthcare expenses for the state.